Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE2
3 participants
INTERVENTIONAL
2007-12-31
2009-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objective of the study is to examine whether lutein supplementation helps to reduce oxidative damage from free radicals in AD patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Lutein and Zeaxanthin Supplementation on Age-related Macular Degeneration
NCT01048476
The Influence of Lutein Supplements on Age-related Macular Degeneration
NCT01042860
The Zeaxanthin and Visual Function Study
NCT00564902
Lutein for Age-Related Macular Degeneration
NCT00006202
The Effects of a Carotenoid Intervention on Cognitive Function
NCT02023645
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Daily Lutein/zeaxanthin supplementation with a meal
lutein/zeaxanthin
daily supplementation of lutein and zeaxanthin at dose of 12 mg/day
2
placebo
placebo capsules with the same size and coating as those of lutein/zeaxanthin supplements without active ingredients
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
lutein/zeaxanthin
daily supplementation of lutein and zeaxanthin at dose of 12 mg/day
placebo
placebo capsules with the same size and coating as those of lutein/zeaxanthin supplements without active ingredients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oregon Partnership for Alzheimer's Research
UNKNOWN
Oregon Health and Science University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wei Wang, PhD
Role: PRINCIPAL_INVESTIGATOR
Oregon Health and Science University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oregon Health and Science University
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Alzheimer research fund
Identifier Type: -
Identifier Source: secondary_id
LAD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.